Citius Oncology, Inc.
CTOR•NASDAQ•Healthcare•Drug Manufacturers - Specialty & Generic

About Citius Oncology

Citius Oncology, Inc. focuses on the development and commercialization of innovative targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. is a subsidiary of Leonard-Meron Biosciences, Inc.

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone908 967 6677
Address
11 Commerce Drive, First Floor Cranford, New Jersey 07016 United States

Corporate Identifiers

CIK0001851484
CUSIP17331Y109
ISINUS17331Y1091
EIN99-4362660
SIC2834

Leadership Team & Key Executives

Leonard L. Mazur
Chief Executive Officer, President and Executive Chairman
Myron Z. Holubiak
Secretary and Executive Vice Chairman
Dr. Myron S. Czuczman M.D.
Executive Vice President and Chief Medical Officer
Jaime Bartushak
Chief Financial Officer and Treasurer